サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/08/26 | 1,178 | 1,273 | 1,174 | 1,225 | +58 | +5% | 1,585,200 |
| 2022/08/25 | 1,129 | 1,172 | 1,126 | 1,167 | +39 | +3.5% | 440,000 |
| 2022/08/24 | 1,123 | 1,135 | 1,112 | 1,128 | +13 | +1.2% | 254,900 |
| 2022/08/23 | 1,095 | 1,121 | 1,094 | 1,115 | +20 | +1.8% | 213,100 |
| 2022/08/22 | 1,105 | 1,111 | 1,094 | 1,095 | -26 | -2.3% | 290,800 |
| 2022/08/19 | 1,123 | 1,135 | 1,103 | 1,121 | -5 | -0.4% | 337,800 |
| 2022/08/18 | 1,139 | 1,145 | 1,112 | 1,126 | -22 | -1.9% | 405,000 |
| 2022/08/17 | 1,142 | 1,167 | 1,136 | 1,148 | +3 | +0.3% | 357,100 |
| 2022/08/16 | 1,145 | 1,170 | 1,143 | 1,145 | ±0 | ±0% | 395,500 |
| 2022/08/15 | 1,140 | 1,157 | 1,130 | 1,145 | +18 | +1.6% | 410,500 |
| 2022/08/12 | 1,140 | 1,141 | 1,111 | 1,127 | +1 | +0.1% | 325,600 |
| 2022/08/10 | 1,159 | 1,166 | 1,121 | 1,126 | -51 | -4.3% | 499,400 |
| 2022/08/09 | 1,116 | 1,183 | 1,116 | 1,177 | +55 | +4.9% | 960,800 |
| 2022/08/08 | 1,125 | 1,136 | 1,104 | 1,122 | -9 | -0.8% | 334,200 |
| 2022/08/05 | 1,104 | 1,133 | 1,095 | 1,131 | +32 | +2.9% | 556,400 |
| 2022/08/04 | 1,080 | 1,104 | 1,071 | 1,099 | +34 | +3.2% | 637,400 |
| 2022/08/03 | 1,075 | 1,079 | 1,058 | 1,065 | +13 | +1.2% | 367,700 |
| 2022/08/02 | 1,097 | 1,107 | 1,050 | 1,052 | -45 | -4.1% | 697,400 |
| 2022/08/01 | 1,069 | 1,103 | 1,063 | 1,097 | +28 | +2.6% | 637,100 |
| 2022/07/29 | 1,030 | 1,069 | 1,026 | 1,069 | +44 | +4.3% | 890,900 |
| 2022/07/28 | 1,058 | 1,066 | 1,022 | 1,025 | -26 | -2.5% | 1,434,500 |
| 2022/07/27 | 1,050 | 1,078 | 1,041 | 1,051 | -11 | -1% | 943,400 |
| 2022/07/26 | 1,080 | 1,110 | 1,033 | 1,062 | -23 | -2.1% | 1,672,100 |
| 2022/07/25 | 1,132 | 1,187 | 1,075 | 1,085 | -227 | -17.3% | 4,868,400 |
| 2022/07/22 | 1,297 | 1,331 | 1,268 | 1,312 | -3 | -0.2% | 795,200 |
| 2022/07/21 | 1,300 | 1,318 | 1,246 | 1,315 | -12 | -0.9% | 1,230,000 |
| 2022/07/20 | 1,387 | 1,387 | 1,295 | 1,327 | -34 | -2.5% | 1,810,300 |
| 2022/07/19 | 1,249 | 1,374 | 1,233 | 1,361 | +125 | +10.1% | 2,698,800 |
| 2022/07/15 | 1,305 | 1,323 | 1,203 | 1,236 | -68 | -5.2% | 2,397,000 |
| 2022/07/14 | 1,211 | 1,398 | 1,167 | 1,304 | +123 | +10.4% | 6,355,600 |
| 2022/07/13 | 1,105 | 1,220 | 1,100 | 1,181 | +78 | +7.1% | 2,464,300 |
| 2022/07/12 | 1,041 | 1,118 | 1,036 | 1,103 | +63 | +6.1% | 1,522,900 |
| 2022/07/11 | 1,033 | 1,040 | 1,028 | 1,040 | +7 | +0.7% | 900,500 |
| 2022/07/08 | 1,027 | 1,034 | 1,020 | 1,033 | +8 | +0.8% | 740,800 |
| 2022/07/07 | 1,028 | 1,031 | 1,008 | 1,025 | -2 | -0.2% | 883,700 |
| 2022/07/06 | 1,030 | 1,035 | 1,023 | 1,027 | -2 | -0.2% | 467,300 |
| 2022/07/05 | 1,031 | 1,033 | 1,020 | 1,029 | -2 | -0.2% | 183,000 |
| 2022/07/04 | 1,035 | 1,039 | 1,007 | 1,031 | -1 | -0.1% | 524,300 |
| 2022/07/01 | 1,066 | 1,066 | 1,027 | 1,032 | -27 | -2.5% | 363,400 |
| 2022/06/30 | 1,111 | 1,117 | 1,056 | 1,059 | -40 | -3.6% | 388,300 |
| 2022/06/29 | 1,130 | 1,137 | 1,099 | 1,099 | -39 | -3.4% | 373,800 |
| 2022/06/28 | 1,135 | 1,169 | 1,127 | 1,138 | -4 | -0.4% | 456,600 |
| 2022/06/27 | 1,160 | 1,166 | 1,134 | 1,142 | -12 | -1% | 336,400 |
| 2022/06/24 | 1,101 | 1,159 | 1,098 | 1,154 | +64 | +5.9% | 805,300 |
| 2022/06/23 | 1,087 | 1,099 | 1,079 | 1,090 | +3 | +0.3% | 217,800 |
| 2022/06/22 | 1,077 | 1,093 | 1,063 | 1,087 | +3 | +0.3% | 250,600 |
| 2022/06/21 | 1,036 | 1,092 | 1,027 | 1,084 | +56 | +5.4% | 368,300 |
| 2022/06/20 | 1,046 | 1,057 | 1,006 | 1,028 | -20 | -1.9% | 349,900 |
| 2022/06/17 | 1,069 | 1,095 | 1,038 | 1,048 | -48 | -4.4% | 616,900 |
| 2022/06/16 | 1,067 | 1,108 | 1,038 | 1,096 | +54 | +5.2% | 948,800 |
651～
700
件表示中 / 2454件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 208,800円 | - | - | 0.00% | - | 96.71倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 413,300円 | +30.5% | +111.0% | 4.60% | 11.65倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 384,500円 | +14.5% | -2.3% | 2.34% | 14.07倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 259,400円 | +15.0% | -7.3% | 2.70% | 8.52倍 | 0.80倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 鳥居薬 | 451,000円 | +7.1% | -35.0% | 2.66% | 37.29倍 | 1.04倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム
